Page last updated: 2024-09-04

beta-lactams and artesunic acid

beta-lactams has been researched along with artesunic acid in 2 studies

Compound Research Comparison

Studies (beta-lactams)	Trials (beta-lactams)	Recent Studies (post-2010) (beta-lactams)	Studies (artesunic acid)	Trials (artesunic acid)	Recent Studies (post-2010) (artesunic acid)
7,579	179	3,395	2,089	443	1,182

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ding, G; Li, B; Li, J; Liu, X; Pan, XC; Ran, D; Wang, N; Wu, C; Yao, Q; Zhang, R; Zheng, J; Zhou, H	1
Cao, H; Cen, Y; Jiang, W; Li, B; Li, J; Liu, X; Pan, X; Zheng, J; Zheng, X; Zhou, H	1

Other Studies

2 other study(ies) available for beta-lactams and artesunic acid

Article	Year
Artesunate enhances the antibacterial effect of {beta}-lactam antibiotics against Escherichia coli by increasing antibiotic accumulation via inhibition of the multidrug efflux pump system AcrAB-TolC. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:4 Topics: Anti-Bacterial Agents; Artemisinins; Artesunate; Bacterial Outer Membrane Proteins; beta-Lactams; Biological Transport; Daunorubicin; Drug Synergism; Escherichia coli; Escherichia coli Proteins; Gene Expression Profiling; Lipoproteins; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins	2011
Artesunate in combination with oxacillin protect sepsis model mice challenged with lethal live methicillin-resistant Staphylococcus aureus (MRSA) via its inhibition on proinflammatory cytokines release and enhancement on antibacterial activity of oxacilli International immunopharmacology, 2011, Volume: 11, Issue:8 Topics: Adenosine; Ampicillin; Animals; Anti-Bacterial Agents; Antigens, CD; Artemisinins; Artesunate; Bacterial Load; beta-Lactams; Cytokines; Down-Regulation; Drug Synergism; Drug Therapy, Combination; Female; Interleukin-6; Macrophages, Peritoneal; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Nod2 Signaling Adaptor Protein; Oxacillin; Penicillin-Binding Proteins; Sepsis; Staphylococcal Infections; Toll-Like Receptor 2; Tumor Necrosis Factor-alpha	2011

Article

Year

Artesunate enhances the antibacterial effect of {beta}-lactam antibiotics against Escherichia coli by increasing antibiotic accumulation via inhibition of the multidrug efflux pump system AcrAB-TolC.

The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:4

Topics: Anti-Bacterial Agents; Artemisinins; Artesunate; Bacterial Outer Membrane Proteins; beta-Lactams; Biological Transport; Daunorubicin; Drug Synergism; Escherichia coli; Escherichia coli Proteins; Gene Expression Profiling; Lipoproteins; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins

2011

Artesunate in combination with oxacillin protect sepsis model mice challenged with lethal live methicillin-resistant Staphylococcus aureus (MRSA) via its inhibition on proinflammatory cytokines release and enhancement on antibacterial activity of oxacilli

International immunopharmacology, 2011, Volume: 11, Issue:8

Topics: Adenosine; Ampicillin; Animals; Anti-Bacterial Agents; Antigens, CD; Artemisinins; Artesunate; Bacterial Load; beta-Lactams; Cytokines; Down-Regulation; Drug Synergism; Drug Therapy, Combination; Female; Interleukin-6; Macrophages, Peritoneal; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Nod2 Signaling Adaptor Protein; Oxacillin; Penicillin-Binding Proteins; Sepsis; Staphylococcal Infections; Toll-Like Receptor 2; Tumor Necrosis Factor-alpha

2011